Regulation of anoikis by extrinsic death receptor pathways

YH Han, Y Wang, SJ Lee, MH Jin, HN Sun… - Cell Communication and …, 2023 - Springer
Metastatic cancer cells can develop anoikis resistance in the absence of substrate
attachment and survive to fight tumors. Anoikis is mediated by endogenous mitochondria …

CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways

L Haymour, M Jean, C Smulski, P Legembre - Biochimica et Biophysica …, 2023 - Elsevier
Although the interaction of CD95L (also known as FasL) with its so-called death receptor
CD95 (Fas) induces an apoptotic signal responsible for the elimination of infected and …

[HTML][HTML] Engineering neoantigens to form immunogenic biopolymer particles targeting metastatic breast cancer

S Pounraj, S Chen, H Triscott, AK Lam, L Ma… - Applied Materials …, 2024 - Elsevier
Cancer vaccines that target tumor-specific neoantigens have shown promising results in
recent clinical trials. However, these vaccines are still in the early stages of development …

Targeted Sensitization of Glioblastoma Multiforme Using AAAPT Technology

M Mendieta, NG Avci, R Pandurangi… - IEEE Open Journal …, 2023 - ieeexplore.ieee.org
Glioblastoma Multiforme (GBM) is the most malignant type of all brain tumors. Current GBM
treatment options include surgery, followed by radiation and chemotherapy. However, GBM …

[PDF][PDF] Targeted Sensitization of Glioblastoma Multiforme Using AAAPT Technology

M Akay, M Mendieta, NG Avci, CC Sanchez… - Authorea …, 2023 - techrxiv.org
Targeted Sensitization of Glioblastoma Multiforme Using AAAPT Technology Page 1 P osted
on 5 Sep 2020 — CC-BY 4.0 — h ttps://doi.org/10.36227/tech rxiv.24076533.v1 — e-Prin ts p …